- Abstract
The safety and tolerability of vortioxetine in adults with major depressive disorder was assessed. Tolerability was based on the nature, incidence and severity of treatment-emergent adverse events (TEAEs) during acute (6/8) week treatment in 11 randomized, double-blind placebo-controlled short-term studies in major depressive disorder:
David S Baldwin et al., J Psychopharmacol. 2016 Mar; 30(3): 242–252.
Published online 2016 Feb 9. doi: 10.1177/0269881116628440